Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy

This publication has 178 references indexed in Scilit:

• Review article: proton pump inhibitors and bacterial overgrowth
  Alimentary Pharmacology & Therapeutics, 2005
• Inhibition of Hydrogen Sulfide Generation Contributes to Gastric Injury Caused by Anti-Inflammatory Nonsteroidal Drugs
  Gastroenterology, 2005
• Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding
  Alimentary Pharmacology & Therapeutics, 2002
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Rebamipide, novel prostaglandin-inducer, accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer comparison with cimetidine
  Digestive Diseases and Sciences, 1995
• Markedly reduced intestinal toxicity of a diclofenac derivative
  Life Sciences, 1994
• Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability
  Digestive Diseases and Sciences, 1993
• Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.
  Gut, 1992
• Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach
  Life Sciences, 1989
• Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)
  Nature, 1972